PLGA encapsulated inactivated-viral vaccine: Formulation and evaluation of its protective efficacy against viral haemorrhagic septicaemia virus (VHSV) infection in olive flounder (Paralichthys olivaceus) vaccinated by mucosal delivery routes
- PMID: 30661835
- DOI: 10.1016/j.vaccine.2018.12.063
PLGA encapsulated inactivated-viral vaccine: Formulation and evaluation of its protective efficacy against viral haemorrhagic septicaemia virus (VHSV) infection in olive flounder (Paralichthys olivaceus) vaccinated by mucosal delivery routes
Abstract
Viral haemorrhagic septicaemia virus (VHSV), an OIE listed viral pathogen, is the etiological agent of a contagious disease, causing huge economic losses in farmed olive flounder (Paralichthys olivaceus) and significant mortalities among several other marine fish species in Korea, Japan, and China. In continuation with our previous work, where injection vaccination with inactivated VHSV mixed with squalene (as adjuvant) conferred higher protective immunity to olive flounder, the present study focused on replacing the injection route of vaccine delivery by immersion/oral route to overcome the limitations of the parenteral immunization method. Here, we encapsulated the inactivated VHSV vaccine with PLGA (poly lactic-co-glycolic acid) nanoparticles (PNPs-IV) and evaluated its ability to induce protective immunity in olive flounder (12.5 ± 1.5 g) by initially immunizing the fishes by immersion route followed by a booster with the same dose two weeks later with half of the fish through immersion route and other half through oral route (incorporated into fish feed). Cumulative mortalities post-challenge (1 × 106 TCID50 virus/fish) with virulent VHSV-isolate, were lower in vaccinated fish and RPS of 60% and 73.3% were obtained for PNPs-IV (immersion/immersion) and PNPs-IV (immersion/oral) groups, respectively. In addition, specific (anti-VHSV) antibody titre in the fish sera, skin mucus and intestinal mucus of the immunized groups were significantly (p < 0.05) enhanced following vaccination. Furthermore, PNPs-IV immunized fish showed significant (p < 0.05) upregulation of different immune gene transcripts (IgM, IgT, pIgR, MHC-I, MHC-II, IFN-γ, and Caspase3) compared to controls, in both the systemic (kidney) and mucosal (skin and intestine) immune compartment of the host post immunization as well as post challenge. Thus it can be inferred that the adopted immunization strategy efficiently protected and transported the inactivated viral antigen to target immune organs and positively stimulated the protective immune response against VHSV in olive flounder.
Keywords: Mucosal immunity; Nanoencapsulation; PLGA; Paralichthys olivaceus; VHSV.
Copyright © 2019. Published by Elsevier Ltd.
Similar articles
-
Nanoencapsulation of inactivated-viral vaccine using chitosan nanoparticles: Evaluation of its protective efficacy and immune modulatory effects in olive flounder (Paralichthys olivaceus) against viral haemorrhagic septicaemia virus (VHSV) infection.Fish Shellfish Immunol. 2019 Aug;91:136-147. doi: 10.1016/j.fsi.2019.05.017. Epub 2019 May 13. Fish Shellfish Immunol. 2019. PMID: 31096061
-
Potential Efficacy of Chitosan-Poly (Lactide-Co-Glycolide)-Encapsulated Trivalent Immersion Vaccine in Olive Flounder (Paralichthys olivaceus) Against Viral Hemorrhagic Septicemia Virus, Streptococcus parauberis Serotype I, and Miamiensis avidus (Scuticociliate).Front Immunol. 2021 Dec 2;12:761130. doi: 10.3389/fimmu.2021.761130. eCollection 2021. Front Immunol. 2021. PMID: 34925332 Free PMC article.
-
Efficacy of Chitosan-PLGA encapsulated trivalent oral vaccine against viral haemorrhagic septicemia virus, Streptococcus parauberis, and Miamiensis avidus in olive flounder (Paralichthys olivaceus).Fish Shellfish Immunol. 2022 Aug;127:843-854. doi: 10.1016/j.fsi.2022.07.029. Epub 2022 Jul 14. Fish Shellfish Immunol. 2022. PMID: 35843523
-
The influence of concentration of inactivated Edwardsiella tarda bacterin and immersion time on antigen uptake and expression of immune-related genes in Japanese flounder (Paralichthys olivaceus).Microb Pathog. 2017 Feb;103:19-28. doi: 10.1016/j.micpath.2016.12.011. Epub 2016 Dec 16. Microb Pathog. 2017. PMID: 27993703 Review.
-
Viral haemorrhagic septicaemia virus in marine fish and its implications for fish farming--a review.J Fish Dis. 2005 Sep;28(9):509-29. doi: 10.1111/j.1365-2761.2005.00654.x. J Fish Dis. 2005. PMID: 16266325 Review.
Cited by
-
The use of nanoparticles in the treatment of infectious diseases and cancer, dental applications and tissue regeneration: a review.Front Med Technol. 2024 Jan 23;5:1330007. doi: 10.3389/fmedt.2023.1330007. eCollection 2023. Front Med Technol. 2024. PMID: 38323112 Free PMC article. Review.
-
High-Level Expression of Recombinant VHSV Glycoprotein Using Transformed C. vulgaris and Verification of Vaccine Efficacy.Vaccines (Basel). 2023 Jul 5;11(7):1205. doi: 10.3390/vaccines11071205. Vaccines (Basel). 2023. PMID: 37515021 Free PMC article.
-
Validation of Multi-epitope Peptides Encapsulated in PLGA Nanoparticles Against Influenza A Virus.Pharm Res. 2023 Aug;40(8):1999-2025. doi: 10.1007/s11095-023-03540-x. Epub 2023 Jun 21. Pharm Res. 2023. PMID: 37344603
-
Nervous Necrosis Virus (NNV) Booster Vaccination Increases Senegalese Sole Survival and Enhances Immunoprotection.Animals (Basel). 2022 Dec 23;13(1):51. doi: 10.3390/ani13010051. Animals (Basel). 2022. PMID: 36611661 Free PMC article.
-
Nanovaccines against Viral Infectious Diseases.Pharmaceutics. 2022 Nov 22;14(12):2554. doi: 10.3390/pharmaceutics14122554. Pharmaceutics. 2022. PMID: 36559049 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous